Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults : a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
Citation
Pickard , R , Starr , K , MacLennan , G , Kilonzo , M , Lam , T , Thomas , R E , Burr , J , Norrie , J , McPherson , G , McDonald , A , Shearer , K , Gillies , K , Anson , K , Boachie , C , N'Dow , J , Burgess , N , Clark , T , Cameron , S & McClinton , S 2015 , ' Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults : a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial) ' , Health Technology Assessment , vol. 19 , no. 63 . https://doi.org/10.3310/hta19630
Rights
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Pickard et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.